Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial
Purpose. The goals of this study were to evaluate the safety and efficacy of an ophthalmic 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)-based nanoemulsion (Nanodrop®) in patients with dry eye disease (DED). Methods. This was a randomized phase I/II multicentric, prospective, double-blind clini...
Saved in:
| Main Authors: | Leopoldo M. Baiza-Durán, Patricia Muñoz-Villegas, Alejandra Sánchez-Ríos, Oscar Olvera-Montaño |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2023/1431473 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Perfluorohexyloctane ophthalmic solution for dry eye disease: pooled analysis of two phase 3 clinical trials
by: Ahmad M. Fahmy, et al.
Published: (2024-11-01) -
Effectiveness evaluation of hyaluronic acid-based commercial eye drops to treat ophthalmic dry eye disease
by: Jon Andrade del Olmo, et al.
Published: (2024-12-01) -
Multi-UAV DMPC Cooperative Guidance with Constraints of Terminal Angle and Obstacle Avoidance
by: Zijie Jiang, et al.
Published: (2024-01-01) -
Effects of Ophthalmic Medications on Conjunctival Goblet Cell Density in New Zealand White Rabbits
by: Sarahi del Carmen Gómez Macías, et al.
Published: (2025-02-01) -
The efficacy and safety of nanoemulsion compared to conventional cyclosporine in dry eye disease: A systematic review and meta-analysis
by: Afaf Bachira Gouhiri, et al.
Published: (2025-10-01)